Literature DB >> 13475624

Physical properties of the red cell agglutinins in acquired hemolytic anemia.

H H FUDENBERG, H G KUNKEL.   

Abstract

The sera of 8 patients with acquired hemolytic anemia associated with elevated levels of cold agglutinins were studied by various procedures of zone electrophoresis. The agglutinating activity was found associated with proteins of variable mobility in the different cases. The majority represented "fast" gamma-globulins. The 4 sera with the highest titers of cold agglutinins showed distinguishable abnormal electrophoretic components. The titers correlated with the height of the abnormal components. Ultracentrifugal analysis of the electrophoretic fractions indicated that the cold agglutinins were associated with proteins having a sedimentation coefficient of approximately 19 S. The abnormal component from the serum with the highest biological activity showed almost no contamination with lower molecular weight proteins. The amount of 19 S material found correlated with the titer of agglutinating activity. The high molecular weight character of the cold agglutinins was confirmed by procedures of density gradient zone centrifugation. The biological activity sedimented with proteins of the 19 S class in all the sera including those of relatively low titer with which no abnormal electrophoretic components were observed. Dissociation of the abnormal high molecular weight components was possible by means of certain sulfhydryl compounds. This resulted in disappearance of cold agglutinin activity. Some of the cases could be classified as macroglobulinemias because of the very large content of high molecular weight components. However, the same disease picture occurred without recognizable elevation of these components. The sera of 3 patients with severe acquired hemolytic anemia of the warm type associated with warm incomplete antibodies failed to show similar abnormal electrophoretic components and the antibody activity sedimented with proteins of the 7 S class.

Entities:  

Keywords:  ANEMIA, HEMOLYTIC/immunology

Mesh:

Substances:

Year:  1957        PMID: 13475624      PMCID: PMC2136816          DOI: 10.1084/jem.106.5.689

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Serum proteins in acquired haemolytic anaemia (auto-antibody type).

Authors:  W N CHRISTENSON; J V DACIE
Journal:  Br J Haematol       Date:  1957-04       Impact factor: 6.998

2.  Ultracentrifugal studies of major non-lipide electrophoretic components of normal human serum.

Authors:  G WALLENIUS; R TRAUTMAN; H G KUNKEL; E C FRANKLIN
Journal:  J Biol Chem       Date:  1957-03       Impact factor: 5.157

3.  Dissociation of human serum macroglobulins.

Authors:  H F DEUTSCH; J I MORTON
Journal:  Science       Date:  1957-03-29       Impact factor: 47.728

4.  Electrophoretic studies on sera containing high-titre cold haemagglutinins: identification of the antibody as the cause of an abnormal gamma 1 peak.

Authors:  W N CHRISTENSON; J V DACIE; B E CROUCHER; P A CHARLWOOD
Journal:  Br J Haematol       Date:  1957-07       Impact factor: 6.998

5.  Cryo- and macroglobulinemia; electrophoretic, ultracentrifugal and clinical studies.

Authors:  I R MACKAY; N ERIKSEN; A G MOTULSKY; W VOLWILER
Journal:  Am J Med       Date:  1956-04       Impact factor: 4.965

6.  Type-specific cold auto-antibodies as a cause of acquired hemolytic anemia and hemolytic transfusion reactions: biologic test with bovine red cells.

Authors:  A S WIENER; L J UNGER; L COHEN; J FELDMAN
Journal:  Ann Intern Med       Date:  1956-02       Impact factor: 25.391

7.  Specificity of auto-antibodies in acquired haemolytic anaemia.

Authors:  J V DACIE; M CUTBUSH
Journal:  J Clin Pathol       Date:  1954-02       Impact factor: 3.411

8.  The preparation and properties of cold hemagglutinin.

Authors:  R S GORDON
Journal:  J Immunol       Date:  1953-10       Impact factor: 5.422

9.  Studies on antibodies eluted from the red cells in autoimmune hemolytic anemia.

Authors:  Z D KOMNINOS; M C ROSENTHAL
Journal:  J Lab Clin Med       Date:  1953-06

10.  Serological findings in a case of haemolytic anaemia, with some general observations on the pathogenesis of this syndrome.

Authors:  W WEINER; D A BATTEY; T E CLEGHORN; F G W MARSON; M J MEYNELL
Journal:  Br Med J       Date:  1953-07-18
View more
  64 in total

1.  COLD AGGLUTININ DISEASE. A REPORT OF SPONTANEOUS REMISSION.

Authors:  L H GOTTLIEB
Journal:  Calif Med       Date:  1964-08

2.  [Diaplacental transmission of auto-anti-bodies].

Authors:  A BEICKERT
Journal:  Klin Wochenschr       Date:  1961-03-01

3.  QUANTITATIVE STUDIES OF THE EFFECT OF RED-BLOOD-CELL SENSITIZATION ON IN VIVO HEMOLYSIS.

Authors:  M CONSTANTOULAKIS; N COSTEA; R S SCHWARTZ; W DAMESHEK
Journal:  J Clin Invest       Date:  1963-11       Impact factor: 14.808

4.  THE NATURE OF ANTIGLOBULIN REACTIVITY OF ANTIBODY TO PENICILLIN.

Authors:  K C WATSON
Journal:  Immunology       Date:  1964-01       Impact factor: 7.397

Review 5.  THE IMMUNOGLOBULINS, WITH SPECIAL REFERENCE TO MACROGLOBULINS AND MACROGLOBULINEMIA.

Authors:  M R MACKENZIE; H H FUDENBERG
Journal:  Calif Med       Date:  1965-09

6.  C-reactive protein in virus infection.

Authors:  W L PARKER; W STACKIW; J C WILT
Journal:  Can Med Assoc J       Date:  1962-10-13       Impact factor: 8.262

7.  Reactivity of red cell eluates and serums in patients with acquired hemolytic anemia and chronic lymphocytic leukemia.

Authors:  J BRODY
Journal:  J Clin Invest       Date:  1962-03       Impact factor: 14.808

8.  [Problem of autoimmune hemolytic anemias].

Authors:  W WEINER
Journal:  Klin Wochenschr       Date:  1960-09-15

9.  Studies on the isolation and characterization of the "rheumatoid factor".

Authors:  H G KUNKEL; E C FRANKLIN; H J MULLER-EBERHARD
Journal:  J Clin Invest       Date:  1959-02       Impact factor: 14.808

10.  The biological significance of the anomalous serum and urinary proteins of myelomatosis, lymphoma, and other conditions.

Authors:  J A OWEN; C GOT
Journal:  J Clin Pathol       Date:  1960-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.